中新药业国际贸易业务拥有三十余年历史，多年来一直坚持走中药国际化道路。截止目前(201509)，已有163个产品在19个国家和地区注册并销售。“长城牌”商标在美国、香港等21个国家及地区进行了注册，老字号商标“达仁堂”牌也于2009年进入国际市场并已在美国、香港、加拿大等8个国家及地区进行了注册。主要出口市场为东南亚、日本、北美、澳大利亚等国家和地区，代表产品有长城清心丸、安宫牛黄丸、乌鸡白凤丸、精制银翘解毒片等。近几年，在中新药业集团开拓海外市场目标的指导下，自2008年以来，公司国际贸易连续六年稳居全国中成药出口前五强企业；2012年，入选“中医药国际化推进十强领军企业”；同年，“长城牌”被授予“天津国际知名品牌”的荣誉称号。

      The international trade of Zhongxin Pharmaceuticals has the history of more than thirty years and keeps to the internationalization of Traditional Chinese Medicine. Up to now,163 products have been registered and sold in 19 countries and regions. The trade mark“Great Wall Brand”has been registered in 21 counries such as America, Hongkong etc; the time-honored brand“Darentang”has been registered in 8 countries such as America, Canada, Hongkong etc. The major export markets are Southeast Asia, Japan, North America, Australia etc., with our representative products Changcheng Qingxin Wan, Angong Niuhuang Wan, Wuji Baifeng Wan, Jingzhi Yinqiao Jiedu Pian etc. In recent years, under the direction of overseas markets development of Zhongxin Pharmaceuticals, the international trade has been ranked as the top five in China for Chinese patent medicine export for six consecutive years since 2008; we were awarded “ Top Ten Enterprises for Internationalization of Chinese Medicine” in 2012; “Great Wall Brand” has been honored“Tianjin International Famous Brand” in the same year.